Asia Pacific Bioprocessing Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)

No. of Pages: 168    |    Report Code: BMIRE00030823    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
Asia Pacific Bioprocessing Market
Buy Now

The Asia Pacific bioprocessing market was valued at US$ 5,488.87 million in 2023 and is expected to reach US$ 16,868.77 million by 2031; it is estimated to register a CAGR of 15.1% from 2023 to 2031.

Proliferating Demand for Personalized Medicine Boosts Asia Pacific Bioprocessing Market



The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle health concerns such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products-many of them for a relatively small group of patients. Therefore, a fundamentally different approach to the production and delivery of biological products may be required. Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The growing number of orphan diseases has increased the demand for biologics and drugs, which has subsequently boosted the growth of personalized medicines. In 2019, the FDA approved ~12 personalized medications for addressing the root causes of disease and further integrated precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program focuses on the innovation of genomics and informatics tools for better diagnosis and treatment of disease. Personalized medicines leverage advances in genetics and bioinformatics to target specific patient populations and treat previously untreatable diseases. Personalized medicine uses bioprocessing techniques to develop tailored therapies. From isolating specific cells to developing patient-specific treatments, bioprocessing steps are essential for producing treatments tailored to each patient. Therefore, the rising demand for personalized medicine is predicted to offer significant growth opportunities to the players operating in the bioprocessing market during the forecast period.

Asia Pacific Bioprocessing Market Overview



The Asia Pacific bioprocessing market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising chronic disease prevalence and favorable reimbursement policies. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the bioprocess technology market in the region. China accounted for the largest share of the market in 2023, and India is expected to record a significant CAGR in the market during the forecast period. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generic-focused landscape to a thriving innovation hub. Additionally, progress in industrialization and the application of novel drugs, high-end medical devices, and techniques contribute to the bioprocessing market growth in China. Thus, an increasing number of research centers, rising government funding, and constant initiatives taken by the market players for geographic expansion fuel the bioprocessing market growth in Asia Pacific.

Asia Pacific Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)
Get more information on this report

Asia Pacific Bioprocessing Strategic Insights

Strategic insights for the Asia Pacific Bioprocessing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-bioprocessing-market-strategic-framework.webp
Get more information on this report

Asia Pacific Bioprocessing Report Scope

Report Attribute Details
Market size in 2023 US$ 5,488.87 Million
Market Size by 2031 US$ 16,868.77 Million
Global CAGR (2023 - 2031) 15.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Instruments and Consumables & Accessories
By Scale of Operation
  • Commercial Operations and Clinical Operations
By Application
  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Protein
  • Cell & Gene Therapy
By End User
  • Biopharmaceutical Companies
  • Contract Manufacturing Organization
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Getinge AB
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Corning Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • 3M Co
  • Eppendorf SE
  • Repligen Corp
  • Entegris Inc
    • Get more information on this report

    Asia Pacific Bioprocessing Regional Insights

    The geographic scope of the Asia Pacific Bioprocessing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-bioprocessing-market-geography.webp
    Get more information on this report


    Asia Pacific Bioprocessing Market Segmentation



    The Asia Pacific bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.

    Based on product, the Asia Pacific bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

    In terms of scale of operation, the Asia Pacific bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.

    By process, the Asia Pacific bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.

    Based on application, the Asia Pacific bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.

    In terms of end user, the Asia Pacific bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.

    By country, the Asia Pacific bioprocessing market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific bioprocessing market share in 2023.

    Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the Asia Pacific bioprocessing market.

    Identical Market Reports with other Region/Countries

    The List of Companies - Asia Pacific Bioprocessing Market

    1. Getinge AB
    2. Thermo Fisher Scientific Inc
    3. Sartorius AG
    4. Corning Inc
    5. Bio-Rad Laboratories Inc
    6. Merck KGaA
    7. 3M Co
    8. Eppendorf SE
    9. Repligen Corp
    10. Entegris Inc
    11. Agilent Technologies Inc
    12. Cytiva US LLC.
    Frequently Asked Questions
    How big is the Asia Pacific Bioprocessing Market?

    The Asia Pacific Bioprocessing Market is valued at US$ 5,488.87 Million in 2023, it is projected to reach US$ 16,868.77 Million by 2031.

    What is the CAGR for Asia Pacific Bioprocessing Market by (2023 - 2031)?

    As per our report Asia Pacific Bioprocessing Market, the market size is valued at US$ 5,488.87 Million in 2023, projecting it to reach US$ 16,868.77 Million by 2031. This translates to a CAGR of approximately 15.1% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Bioprocessing Market report typically cover these key segments-

    • Product (Instruments and Consumables & Accessories)
    • Scale of Operation (Commercial Operations and Clinical Operations)
    • Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy)
    • End User (Biopharmaceutical Companies, Contract Manufacturing Organization)

    What is the historic period, base year, and forecast period taken for Asia Pacific Bioprocessing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Bioprocessing Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in Asia Pacific Bioprocessing Market?

    The Asia Pacific Bioprocessing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Getinge AB
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Corning Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • 3M Co
  • Eppendorf SE
  • Repligen Corp
  • Entegris Inc
  • Agilent Technologies Inc
  • Cytiva US LLC.
    • Who should buy this report?

    The Asia Pacific Bioprocessing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Bioprocessing Market value chain can benefit from the information contained in a comprehensive market report.

    asia-pacific-bioprocessing-market